Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung

E. S. Casper, R. J. Gralla, D. P. Kelsen, A. Houghton, R. B. Golbey, C. W. Young

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung'. Together they form a unique fingerprint.

Medicine & Life Sciences